Skip to main content
S&P 5007,591.70-0.58%DOW52,064.10-0.60%NASDAQ26,081.72-0.65%BTC$76,799.00-1.71%ETH$2,453.65-0.48%GOLD$4,367.20-0.91%OIL$103.26+0.76%
Smart Investors Daily
HR

NYSE · HRT

HireRight Holdings Corporation

Industrials · Staffing & Employment Services

$14.36

Down-$0.02 (-0.14%)

Updated Sep 11, 2026, 9:38 AM

SID Score

—

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
967.19M
P/E ratio
-90.6
Dividend yield
0.00%
52-week range
— – —
Volume
2.24M
Avg. volume
219.74K

Price performance

HRT price history

1M range · 0 trading sessions · Daily adjusted prices

HRT does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest HRT news

The latest Smart Investors Daily articles mentioning HRT.

Stock researchCompany · Overview

HRT research

Overview

Company profile and research snapshot.

Company profile

HireRight Holdings Corporation provides technology-driven workforce risk management and compliance solutions worldwide. The company offers background screening, verification, identification, monitoring, and drug and health screening services for customers. It provides its services through software and data platform that integrates into its customers' human capital management systems enabling workflows for workforce hiring, onboarding, and monitoring. The company was incorporated in 1990 and is based in Nashville, Tennessee.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Hold
Average target
$14.00
Implied upside
—
Analysts
12
HRT recent ratings
DateFirmRatingTarget
Feb 16, 2024NeedhamHold—
Dec 11, 2023NeedhamBuy—
Nov 8, 2023Truist SecuritiesHold—
Oct 3, 2023NeedhamBuy—
Aug 9, 2023NeedhamBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Benzinga · Jan 4, 2024

Equifax Named Top Pick For 2024 By Needham, Price Target Raised On Expected Mortgage Rate Tailwinds

Needham analyst Kyle Peterson maintains Equifax Inc (NYSE: EFX) with a Buy and raises the price target from $230 to $305. The analyst highlights EFX as his Top Pick 2024 and adds it to the Needham Conviction List, replacing HireRight Holdings Corp (NYSE: HRT).  While EFX's fundamentals have faced pressure since mid-FY22 due to a spike in mortgage rates, the analyst expects the recent decline in interest rates to serve as a sizable tailwind heading into 2024.  In addition, EFX's non-mortgage businesses have been performing well. They are scaling through new products, pricing increases, and ...Full story available on Benzinga.com

Benzinga · Sep 13, 2023

Dow Turns Lower; KULR Technology Group Shares Plummet

U.S. stocks traded mixed toward the end of trading, with the Dow Jones falling 100 points on Wednesday. The Dow traded down 0.29% to 34,545.66 while the NASDAQ rose 0.22% to 13,803.43. The S&P 500, also rose, gaining, 0.01% to 4,462.11. Check This Out: These 3 Health Care Stocks With Over 3% Dividend Yields Are Recommended By Wall Street's Most Accurate Analysts   Leading and Lagging Sectors Utilities shares jumped by 1.6% on Wednesday. In trading on Wednesday, real estate shares fell by 1%.   Top Headline The annual inflation rate in the U.S. rose for a second consecutive month to 3.7% in August from 3.2% in the previous month, and also above market estimates of 3.6%. Consumer prices increased 0.6% month-over-month in August following a 0.2% growth in July.   Equities Trading UP HireRight Holdings Corporation (NYSE: HRT) shares shot up 13% to $9.91. HireRight plans additional $25 million share repurchase program. Shares of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) got a boost, shooting 37% to $20.91 after the company announced that alignment has been reached with the FDA on the global Phase 2 pivotal trial of RP-A501 for Danon Disease. DZS Inc. (NASDAQ: DZSI) shares were also up, gaining 28% to $2.35. DZS secured $29.7 million in financing.

Benzinga · Sep 13, 2023

Dow Gains 50 Points; US Crude Oil Inventories Rise

U.S. stocks traded higher midway through trading, with the Dow Jones gaining around 50 points on Wednesday. The Dow traded up 0.16% to 34,701.06 while the NASDAQ rose 0.44% to 13,834.85. The S&P 500, also rose, gaining, 0.30% to 4,475.23. Check This Out: These 3 Health Care Stocks With Over 3% Dividend Yields Are Recommended By Wall Street's Most Accurate Analysts   Leading and Lagging Sectors Consumer discretionary shares jumped by 0.7% on Wednesday. In trading on Wednesday, energy shares fell by 0.4%.   Top Headline U.S. crude oil inventories climbed by 3.954 million barrels in the week ending Sept. 8, 2023, versus market estimates of a 1.912 million decline, the EIA reported.   Equities Trading UP HireRight Holdings Corporation (NYSE: HRT) shares shot up 17% to $10.20. HireRight plans additional $25 million share repurchase program. Shares of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) got a boost, shooting 43% to $21.88 after the company announced that alignment has been reached with the FDA on the global Phase 2 pivotal trial of RP-A501 for Danon Disease. DZS Inc. (NASDAQ: DZSI) shares were also up, gaining 31% to $2.3998. DZS secured $29.7 million in financing.   Equities Trading DOWN Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR) shares dropped ...

Benzinga · Mar 10, 2023

Goldman Sachs Maintains Buy Rating for HireRight Holdings: Here's What You Need To Know

Goldman Sachs has decided to maintain its Buy rating of HireRight Holdings (NYSE:HRT) and lower its price target from $15.60 to $13.80. Shares of HireRight Holdings are trading up 6.63% over the last 24 hours, at $10.77 per share. A move to $13.80 would account for a 28.13% increase from the current share price. About HireRight Holdings HireRight Holdings Corp is a global provider of technology-driven workforce risk management and compliance solutions. It provides comprehensive background screening, verification, identification, monitoring, and drug and health screening services. It offers services via a unified global software and data platform that tightly integrates into ...Full story available on Benzinga.com

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By